China says talks to include Paxlovid in its health insurance drug list fail

日本 ニュース ニュース

China says talks to include Paxlovid in its health insurance drug list fail
日本 最新ニュース,日本 見出し
  • 📰 STForeignDesk
  • ⏱ Reading Time:
  • 37 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 71%

The antiviral drug is currently covered by China's broad healthcare insurance scheme under temporary measures. Read more at straitstimes.com.

BEIJING - China will not include Pfizer Inc’s Paxlovid in an update to its list of medicines covered by basic medical insurance schemes as the US firm quoted a high price for the Covid-19 drug, China’s Healthcare Security Administration said on Sunday.

Inclusion on the list means a drug is accessible via state insurance schemes, which will boost volumes but comes with the condition that manufacturers lower prices. Past rounds have seen drugmakers cut prices by as much as 62 per cent after negotiations with officials.The NHSA said Paxlovid would continue to be eligible to be paid for by state medical insurance until the current planned end-date to the temporary measures of March 31.

The sudden loosening of restrictions has fueled a giant wave of infections and prompted many to turn to underground channels to procure remedies such as Paxlovid, which a clinical trial has found to have reduced hospitalisations in high-risk patients by around 90 per cent.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

STForeignDesk /  🏆 4. in SG

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

China in talks with Pfizer for generic Covid-19 drug: SourcesChina in talks with Pfizer for generic Covid-19 drug: SourcesHONG KONG/BEIJING – China is in talks with Pfizer Inc to secure a licence that will allow domestic drugmakers to manufacture and distribute a generic version of the US firm's Covid-19 antiviral drug Paxlovid in China, three sources told Reuters. China's medical products regulator – the National Medical Products Administration (NMPA) – has been leading the talks with Pfizer since...
続きを読む »

China in talks with Pfizer for generic Covid-19 drug: SourcesChina in talks with Pfizer for generic Covid-19 drug: SourcesBeijing is keen to finalise licensing deal terms before the Lunar New Year which begins on Jan 22. Read more at straitstimes.com.
続きを読む »

China's boom in sustainable bonds lacks rigour, warns FitchChina's boom in sustainable bonds lacks rigour, warns FitchLONDON : Chinese companies and state-owned enterprises are increasingly turning to green and sustainable bond markets to finance China's national climate strategy, but the bonds often fall short of international standards, according to ratings agency Fitch. Chinese firms raised $186 billion through domest
続きを読む »

China’s NetEase buys Halo co-developer SkyBox Labs in global expansion driveChina’s NetEase buys Halo co-developer SkyBox Labs in global expansion driveHONG KONG : NetEase Inc said on Friday it had acquired Canadian gaming studio SkyBox Labs, best known for co-developing hits including Halo Infinite and Minecraft, as China’s second largest video games firm steps up a global expansion effort. The Hangzhou-based company did not disclose the size of the d
続きを読む »

Netherlands, Portugal require COVID-19 tests for China arrivalsNetherlands, Portugal require COVID-19 tests for China arrivalsTHE HAGUE: The Dutch and Portuguese governments on Friday (Jan 6) joined a growing number of nations requiring air passengers arriving from China to show a negative COVID-19 test upon entry. More than a dozen countries have slapped fresh travel regulations on travellers from the world's most populous natio
続きを読む »

US cuts naval transits through Taiwan Strait even as China steps up military pressureThe US 7th Fleet sent nine warships through the Taiwan Strait. Read more at straitstimes.com.
続きを読む »



Render Time: 2025-03-31 20:25:06